| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/08/2008 | WO2008033058A3 Method for producing insulin in the form of an oral preparation |
| 05/08/2008 | WO2008032059A3 Growth factor |
| 05/08/2008 | WO2008021795A3 Flowable carrier matrix |
| 05/08/2008 | WO2008015099A3 Pegylated, extended insulins |
| 05/08/2008 | WO2008012689A3 Cytokine derivatives |
| 05/08/2008 | WO2008012629A3 Exendin fusion proteins |
| 05/08/2008 | WO2008011344A3 Disruption of programmed death-1 (pd-1) ligands to adjuvant adeno-associated virus vector vaccines |
| 05/08/2008 | WO2007149381A3 Compositions comprising a ptp-ase inhibitor and use thereof in treating cancer |
| 05/08/2008 | WO2007143957A3 'transfer factor' medicament - ways of manufacturing and use |
| 05/08/2008 | WO2007143689A8 Compositions and methods for modulating vascular development |
| 05/08/2008 | WO2007113285A3 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
| 05/08/2008 | WO2007112403A3 Prevention and treatment of ischemia-reperfusion injury |
| 05/08/2008 | WO2007095530A3 Diagnostic kits to detect sp22 and sp22 antibodies |
| 05/08/2008 | WO2006056487A3 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 05/08/2008 | US20080109917 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 05/08/2008 | US20080109654 System and method for RFID transfer of MAC, keys |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108797 Modified Human Growth Hormone Polypeptides and Their Uses |
| 05/08/2008 | US20080108796 Human IL-1 epsilon DNA and polypeptides |
| 05/08/2008 | US20080108791 Modified Human Interferon Polypeptides and Their Uses |
| 05/08/2008 | US20080108788 Cell surface receptor for use as tool in identifying modulators of vascular pressure |
| 05/08/2008 | US20080108778 Lactic acid-glycolic acid polymer having ratio or weight average molecular weight and number average molecular weight of about 1.90 or lower, or a salt thereof, and a physiologically active substance; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, breast cancer |
| 05/08/2008 | US20080108581 consist of DNA sequence-specific ligand capable of recognizing sequence common to genes of pathological interest ( as IGF-1, IGF-1R, VEGF, BCL2), linker arm, and topoisomerase I posion (as camptothecins, rebeccamycins, minor groove ligands, benzimidazoles); dismetabolic, autoimmune diseases, HIV and HCV |
| 05/08/2008 | US20080108577 sealing vascular system apertures, by mixing aminotrimethylolmethane buffer , an electrophilic polyoxyethyelne glycol or ethylene oxide adduct and nucleophilic proteins, that croslinks to form solid, three-dimensional barriers, then applying the mixture to seal the apertures; biocompatibility |
| 05/08/2008 | US20080108576 Novel cytostatic conjugates with integrin ligands |
| 05/08/2008 | US20080108575 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 05/08/2008 | US20080108574 Melanocortin receptor mediated modulation of neurogenesis |
| 05/08/2008 | US20080108573 Compositions And Methods For Treatment Of Cardiovascular Disease |
| 05/08/2008 | US20080108572 measuring the level of relaxin expression in a pregnant woman, comparing measured level of relaxin to a level of relaxin associated with normal placental development , a lower measured level of relaxin correlates with an increased risk of developing a condition associated with placental insufficiency |
| 05/08/2008 | US20080108571 folliculogenesis and follicular maturation without ovarian hyperstimulation; contain various FSH-to-hCG ratios and a carrier; enable the practitioner to optimize ovulatory stimulation in flexible manner |
| 05/08/2008 | US20080108570 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyalkyl starch; genetic engineered albumin |
| 05/08/2008 | US20080108569 Compositions and Methods for Treating Diseases Associated With Phlpp |
| 05/08/2008 | US20080108568 administering a sulfonamide compound containing quinoline and 1,4-diazapine rings, with a nitric oxide enhancer selected from the group consisting of a PDE5 inhibitor, a nitric oxide donor molecules, or a HMG Co A Reductase |
| 05/08/2008 | US20080108567 Leptin-related peptides |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108565 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF |
| 05/08/2008 | US20080108564 Peptide covalently bound to Polyethylene glycol; agonists of the erythropoietin receptor (EPO-R), having amino acid sequence; defective red blood cell production |
| 05/08/2008 | US20080108563 Glial Cell line-derived Neurotrophic Factor Receptor; neuronal disorders, Parkinson's, Alzheimers or neuronal injury |
| 05/08/2008 | US20080108562 administering PTH receptor agonist; bone loss, bone fracturing, and/or reduce pain |
| 05/08/2008 | US20080108561 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases |
| 05/08/2008 | US20080108560 Heterologous G-Csf Fusion Proteins |
| 05/08/2008 | US20080108559 Compositions and methods for treating diseases through inhibition of dna methylation and histone deacetylase |
| 05/08/2008 | US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/08/2008 | US20080108557 Conjugating peptides and proteins using glycosyltransferase; nontoxic; increasing bioactivity |
| 05/08/2008 | US20080108556 Activating expression of an endogenous Pigment Epithelium Derived Factor gene in one or more cells of an organism; ocular neovascularization in an organism |
| 05/08/2008 | US20080108555 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute |
| 05/08/2008 | US20080108554 Method and apparatus for producing dry particles |
| 05/08/2008 | US20080108553 Rationally designed media for cell culture |
| 05/08/2008 | US20080108552 Beta 1-integrin inhibitory peptide modified by biotin, cystein, or carboxyfluorescein (FAM) |
| 05/08/2008 | US20080108551 Treatment of wounds |
| 05/08/2008 | US20080108550 Hdl for the treatment of stroke and other ischemic conditions |
| 05/08/2008 | US20080108549 Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia |
| 05/08/2008 | US20080108548 Food Composition For Rapidly Attenuating Inflammatory Responses |
| 05/08/2008 | US20080108547 Protease Inhibitor |
| 05/08/2008 | US20080108546 Novel Human Card-Only Protein That Inhibits Pro-Il-1 Beta Maturation |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080108149 Solid-phase mediated synthesis of molecular microarrays |
| 05/08/2008 | US20080108139 Composition of matter comprising primary nucleic acid component |
| 05/08/2008 | US20080108135 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 05/08/2008 | US20080108093 Identifying compounds for use in treatment and prevention bone disorders |
| 05/08/2008 | US20080108086 Parathyroid hormone antagonists and uses thereof |
| 05/08/2008 | US20080108066 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein |
| 05/08/2008 | US20080107775 Improves the temporal profile and/or flavor profile by imparting a more sugar-like temporal profile and/or flavor profile |
| 05/08/2008 | US20080107763 Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
| 05/08/2008 | US20080107762 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 05/08/2008 | US20080107724 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107717 Methods and materials including treating acne related applications |
| 05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
| 05/08/2008 | US20080107709 Radio-opaque polymeric biomaterials |
| 05/08/2008 | US20080107708 Protoelastin made from human recombinant tropoelastin, splice variants of tropoelastin, chemically modified tropoelastin, recombinant tropoelastin fragments, tropoelastin covalently bound to a metal, ceramic, bone, or polymeric substrate, a tropoelastin-polymer laminate |
| 05/08/2008 | US20080107707 Polymerizable antimicrobial composition |
| 05/08/2008 | US20080107705 Administering locally for disc disorders |
| 05/08/2008 | US20080107694 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders |
| 05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/08/2008 | US20080107673 Clostridial polypeptide for use in prevention and treatment of microorganismal infcetion |
| 05/08/2008 | US20080107667 Fusion peptide for use in targeting cells for lympocytic destruction; immunotherapy |
| 05/08/2008 | US20080107666 Non-Glycosylated Recombinant Collagen-Like Polypeptides |
| 05/08/2008 | US20080107662 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis |
| 05/08/2008 | US20080107661 Using cell free system for identifying agents which prevent mucin and chronic myelogenous leukemia ligand binding; antitumor agents; treating cell proliferative, nervous system, inflammatory and atherosclerotic disorders |
| 05/08/2008 | US20080107660 Binding Agents |
| 05/08/2008 | US20080107656 Plasmodium specific immunoglobulin for use in prevention and treatment of parasitic infection; parasiticides |
| 05/08/2008 | US20080107651 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 05/08/2008 | US20080107650 Administering (S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid for treatment of inflammatory bowel disease, Crohn's disease; corticosteroid free therapy |
| 05/08/2008 | US20080107641 Treating ischemic events in humans via administration of tissue plasminogen activator; antiischemic agents |
| 05/08/2008 | US20080107640 Biological pesticide |
| 05/08/2008 | US20080107639 Secreted glycoprotein for use in prevention and treatment of obesity, diabetes, osteoarthritis, liver and hypertensive disorders |
| 05/08/2008 | US20080107638 Mixture comprising long-chain primary aliphatic alcohol, B12 Vitamin, D Vitamin, coenzyme Q, and omega-3 fatty for use in prevention and treatment of tissue destructive inflammation |
| 05/08/2008 | US20080107637 Using inhalabe gas comprising ethyl nitrite as means of nitrosylating hemoglobin, delaying tumor growth and preventing destruuctive tissue damage associated with inflammation |
| 05/08/2008 | US20080107634 Using mix comprising bifidobacterium and lactobacillus as tool in treatment of gastrointestinal and influenzal disorders |
| 05/08/2008 | US20080107632 Mixture comprising blood clotting component, fibrinogen, aprontin and calcium for use in treatment of nervous system injury |
| 05/08/2008 | US20080107628 Phosphonate inhibitors of HCV |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107626 Adjuvant agent for hepatitis C |
| 05/08/2008 | US20080107625 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107624 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107623 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107622 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |